Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells. 2004

Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
Molecular Tumor Biology and Tumor Immunology group, Department I of Internal Medicine, University of Cologne, Germany. Roman.Thomas@uni-koeln.de

Classic Hodgkin's lymphoma is characterised by Hodgkin and Reed-Sternberg cells and in most cases are derived from germinal-centre B cells. Despite progress in basic research showing the natural precursor cells of Hodgkin's lymphoma, most key questions still remain unanswered. Among these are the basic transforming events, the involvement of oncogenic viruses, the mechanisms enabling Hodgkin and Reed Sternberg cells to resist apoptosis in the germinal centre, and the molecular causes of their characteristic phenotype. Beyond the disclosure of these issues, the detection of changes in gene expression, gene mutations, and chromosomal imbalances specific of Hodgkin's lymphoma are central to recent research that may allow one a better understanding of the natural history of this type of lymphoma.

UI MeSH Term Description Entries
D008967 Molecular Biology A discipline concerned with studying biological phenomena in terms of the chemical and physical interactions of molecules. Biochemical Genetics,Biology, Molecular,Genetics, Biochemical,Genetics, Molecular,Molecular Genetics,Biochemical Genetic,Genetic, Biochemical,Genetic, Molecular,Molecular Genetic
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D016539 Reed-Sternberg Cells Large cells, usually multinucleate, whose presence is a common histologic characteristic of classical HODGKIN DISEASE. Sternberg-Reed Cells,Cells, Reed-Sternberg,Cells, Sternberg-Reed,Reed Sternberg Cells,Sternberg Reed Cells
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
April 2006, International journal of cancer,
Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
June 1999, Cancer treatment reviews,
Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
May 2003, International journal of hematology,
Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
November 2020, Diagnostics (Basel, Switzerland),
Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
November 2008, Ai zheng = Aizheng = Chinese journal of cancer,
Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
May 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
July 1995, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
January 1998, Annual review of immunology,
Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
May 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Roman K Thomas, and Daniel Re, and Jürgen Wolf, and Volker Diehl
August 2014, Blood,
Copied contents to your clipboard!